Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial
- 601 Downloads
A multicenter phase II clinical study was performed in patients with T3 or T4 stage II/III rectal cancer to evaluate the efficacy and safety of neoadjuvant chemotherapy with 5-fluorouracil, levofolinate, and oxaliplatin (mFOLFOX6).
Patients received four 2-week cycles of mFOLFOX6 therapy (oxaliplatin at 85 mg/m2 + leucovorin at 200 mg/m2 + fluorouracil as a 400 mg/m2 bolus followed by infusion of 2400 mg/m2 over 46 h, all on Day 1). They were evaluated by computed tomography after completion of the fourth cycle. If there was no disease progression, two additional cycles were administered and then surgery was performed. Adjuvant chemotherapy was generally administered for 6 months using appropriate regimens at the discretion of the physician.
mFOLFOX6 therapy was given to 52 patients with locally advanced rectal cancer. The preoperative response rate was 48.8% and the operation rate was 80.8%. Serious adverse events of Grade 3–4 were neutropenia (n = 5), leukopenia (n = 1), thrombocytopenia (n = 1), febrile neutropenia (n = 1), nausea (n = 1), vomiting (n = 1), and peripheral neuropathy (n = 2). The R0 resection rate, pathologic complete response rate, and sphincter preservation rate were 91.0, 11.9, and 73.8%, respectively. Postoperative complications were tolerable.
The present results suggested that neoadjuvant therapy with mFOLFOX6 is safe and effective, representing a reasonable treatment option for locally advanced rectal cancer.
KeywordsmFOLFOX6 Rectal cancer Resectable Neoadjuvant chemotherapy Preoperative chemotherapy
Compliance with ethical standards
Conflict of interest
The authors had no commercial interest in the study subject. No financial or material support was received in conjunction with this work.
- 1.Cancer Registry and Statistics. Cancer Information Service, National Cancer Center, JapanGoogle Scholar
- 9.Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215–1223CrossRefPubMedGoogle Scholar
- 10.Latkauskas T, Pauzas H, Gineikiene I et al (2012) Initial results of randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery. Colorectal Dis 14:294–298CrossRefPubMedGoogle Scholar
- 13.Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Eng J Med 336:980–987Google Scholar
- 17.Fernández-Martos C, Pericay C, Aparicio J et al (2010) Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Group cancer de recto 3 study. J Clin Oncol 28:859–865CrossRefPubMedGoogle Scholar
- 21.Neoadjuvant FOLFOX6 chemotherapy with or without radiation in rectal cancer (FOWARC). https://clinicaltrials.gov/ct2/show/NCT01211210 (2010). Accessed 16 Jun 2015
- 22.Harrison M, Beare S, Bridgewater, JA et al (2014) Bevacizumab and combination chemotherapy in rectal cancer until surgery (BACCHUS): a phase II, multicenter, open-label, randomized study of neoadjuvant chemotherapy alone without radiation in patients with MRI-defined high-risk cancer of the rectum not threatening the circumferential margin. J Clin Oncol 32:5s (suppl; abstr TPS3653) CrossRefGoogle Scholar
- 25.Kotaka M, Yoshino T, Oba K, et al (2015) Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial). Cancer Chemother Pharmacol [Epub ahead of print] Google Scholar